Chapter 7 – Imaging White Matter Pathology in Epilepsy
Chapter 7 Imaging White Matter Pathology in Epilepsy Min Liu , Luis Concha , Boris C. Bernhardt , Neda Bernasconi and Andrea Bernasconi 7.1 Introduction While the study of the…
Chapter 7 Imaging White Matter Pathology in Epilepsy Min Liu , Luis Concha , Boris C. Bernhardt , Neda Bernasconi and Andrea Bernasconi 7.1 Introduction While the study of the…
Chapter 6 Computational Neuroimaging of Epilepsy Seok-Jun Hong , Min Liu , Ravnoor Gill , Edward Hogan , Neda Bernasconi and Andrea Bernasconi 6.1 Introduction Epilepsy, a disorder of the…
Chapter 10 Interictal and Ictal Brain Network Changes in Focal Epilepsy Mangor Pedersen , Amir Omidvarnia and Graeme D. Jackson 10.1 Introduction Focal epilepsy was in 2005 redefined as a…
Chapter 4 Imaging and Cognition in Children with New-Onset Epilepsies Kevin Dabbs , Camille Garcia-Ramos , Daren Jackson , Jack Lin , Sam Bobholz , Dace Almane , Jana Jones…
Chapter 11 Ictal Events Imaged through SPECT Elson L. So , Vlastimil Sulc , Gregory Worrell and Benjamin H. Brinkmann 11.1 Introduction Brain perfusion alterations could conceivably serve as a…
Chapter 5 Imaging Genetics for Benign Mesial Temporal Lobe Epilepsy Antonio Gambardella and Angelo Labate 5.1 Introduction Temporal lobe epilepsy (TLE) represents the most common type of focal epilepsy in…
Chapter 2 Experimental MRI Approaches to Study Posttraumatic Epilepsy Olli Gröhn and Alejandra Sierra 2.1 Introduction The long-term consequences of a brain trauma and the magnitude of this problem are…
Chapter 1 Imaging Biomarkers for Febrile Status Epilepticus and Other Forms of Convulsive Status Epilepticus Rodney C. Scott 1.1 Introduction Status epilepticus was originally conceived as the “maximal expression” of…
1 Chapter 1 : Fundamentals of neuropathology: introduction to neuropathology and molecular diagnostics a. Classification of glioblastoma i. Microvascular proliferation and pseudopalisading necrosis are pathologic hallmarks of glioblastoma (GBM) and,…
Introduction Immune-based therapies have revolutionized cancer treatment. These agents enhance the immune system’s ability to seek out and attack tumor cells. One such treatment, CAR T-cells or chimeric antigen receptor…